- AUD/USD bulls attack 0.6980 following the latest bounce off 0.6961.
- Market sentiment remains mixed with equities on the positive side amid better earnings reports, virus woes, Sino-American tussle prevail.
- Second-tier Aussie data can offer immediate direction, risk catalysts to keep the driver’s seat.
AUD/USD remains on the front foot around 0.6980 at the start of Wednesday’s Asian session. The pair snapped the previous three-day losing streak the previous day after reversing from 0.6920. Though, 0.7000 threshold remains as the key resistance for the bulls to clear.
While the recent announcement from Moderna offers the latest push to the Aussie pair, upbeat performance by Wall Street benefited the quote before that. It’s worth mentioning that the risk-on mood has nothing to do with the US-China tension with fewer positives from the coronavirus (COVID-19) front.
Bulls track Wall Street gains…
The returns of the equity buyers renewed optimism in the global markets. Upbeat earnings from the key banks like JP Morgan and Citi managed to dim the previous economic fears. It should, however, be noted that the banks are direct beneficiaries of the latest stimulus and hopes of some more adds to the upbeat trading sentiment.
Read: Wall Street Close: Bulls clinch onto bullish territory by the tops of their hooves
Recently, Moderna came with the news, per CNBC, suggesting that their vaccine produced a ‘robust’ immune response during the third trial. The update follows other positive announcements that have crossed wires off-late suggesting that the global pharmacy companies are near to a cure to the pandemic.
Talking about the tensed relations among the world’s top two economies, namely the US and China, the South China Sea has recently been in limelight after US Secretary of State Mike Pompeo defied Beijing's claim over the region and the dragon nation responded accordingly. In his latest press conference, US President Donald Trump said to sign the previously approved bill by the House to levy sanctions on China over the Hong Kong security bill.
Concerning the data, American inflation numbers came in mixed after upbeat marks of the National Australia Bank’s Business Confidence and Business Conditions. Further, China’s trade data also suggests that the dragon nation is gradually overcoming the virus-led economic halt.
Moving on, global traders will keep eyes on the pandemic updates, Sino-American tension for fresh impulse. Additionally, Australia’s Westpac Consumer Confidence and HIA New Home Sales, for July and May respectively, will also be followed for fresh impetus. While the economics and vaccine news might help the quote to keep 0.7000 on the bulls’ radars, other factors concerning China could question further upside.
Technical analysis
Unless witnessing a daily close beneath the monthly support line, currently around 0.6925, buyers are less likely to forget attacking 0.7000 mark.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
AUD/USD hovers around 0.6500 amid light trading, ahead of US GDP
AUD/USD is trading close to 0.6500 in Asian trading on Thursday, lacking a clear directional impetus amid an Anzac Day holiday in Australia. Meanwhile, traders stay cautious due ti risk-aversion and ahead of the key US Q1 GDP release.
USD/JPY finds its highest bids since 1990, near 155.50
USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, testing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming Japanese intervention risks. Focus shifts to Thursday's US GDP report and the BoJ decision on Friday.
Gold stays firm amid higher US yields as traders await US GDP data
Gold recovers from recent losses, buoyed by market interest despite a stronger US Dollar and higher US Treasury yields. De-escalation of Middle East tensions contributed to increased market stability, denting the appetite for Gold buying.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price. Coupled with broader market gloom, INJ token’s doomed days may not be over yet.
Meta Platforms Earnings: META sinks 10% on lower Q2 revenue guidance Premium
This must be "opposites" week. While Doppelganger Tesla rode horrible misses on Tuesday to a double-digit rally, Meta Platforms produced impressive beats above Wall Street consensus after the close on Wednesday, only to watch the share price collapse by nearly 10%.